Cargando…

Complementary Dual Approach for In Silico Target Identification of Potential Pharmaceutical Compounds in Cystic Fibrosis

Cystic fibrosis is a genetic disease caused by mutation of the CFTR gene, which encodes a chloride and bicarbonate transporter in epithelial cells. Due to the vast range of geno- and phenotypes, it is difficult to find causative treatments; however, small-molecule therapeutics have been clinically a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinhoven, Liza, Stanke, Frauke, Hafkemeyer, Sylvia, Nietert, Manuel Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604016/ https://www.ncbi.nlm.nih.gov/pubmed/36293229 http://dx.doi.org/10.3390/ijms232012351

Ejemplares similares

CFTR Lifecycle Map—A Systems Medicine Model of CFTR Maturation to Predict Possible Active Compound Combinations
por: Vinhoven, Liza, et al.
Publicado: (2021)

Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
por: Nietert, Manuel Manfred, et al.
Publicado: (2021)

Integrating Text Mining into the Curation of Disease Maps
por: Voskamp, Malte, et al.
Publicado: (2022)

Mapping Compound Databases to Disease Maps—A MINERVA Plugin for CandActBase
por: Vinhoven, Liza, et al.
Publicado: (2021)

VJ Segment Usage of TCR-Beta Repertoire in Monozygotic Cystic Fibrosis Twins
por: Fischer, Sebastian, et al.
Publicado: (2021)

An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion
por: Stanke, Frauke, et al.
Publicado: (2011)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

CLCA4 variants determine the manifestation of the cystic fibrosis basic defect in the intestine
por: Kolbe, Ernst-Wolfgang, et al.
Publicado: (2013)

Spontaneous rescue from cystic fibrosis in a mouse model
por: Charizopoulou, Nikoletta, et al.
Publicado: (2006)

Instability of the insertional mutation in Cftr(TgH(neoim)Hgu )cystic fibrosis mouse model
por: Charizopoulou, Nikoletta, et al.
Publicado: (2004)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
por: Fukuda, Ryosuke, et al.
Publicado: (2020)

Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia
por: Stanke, Frauke, et al.
Publicado: (2010)

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients
por: Wetzstein, Nils, et al.
Publicado: (2022)

In silico identification of anti-aging pharmaceutics from community knowledge
por: Beck, Samuel, et al.
Publicado: (2021)

Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis
por: Dey, Isha, et al.
Publicado: (2016)

Very mild disease phenotype of congenic Cftr(TgH(neoim)Hgu )cystic fibrosis mice
por: Tóth, Balázs, et al.
Publicado: (2008)

Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
por: Stanke, Frauke, et al.
Publicado: (2023)

Identification of a Mutation in the Novel Compound Heterozygous CFTR in a Chinese Family with Cystic Fibrosis
por: Shao, Hongxia, et al.
Publicado: (2020)

In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis
por: Trouvé, Pascal, et al.
Publicado: (2017)

In Silico Models for Ecotoxicity of Pharmaceuticals
por: Roy, Kunal, et al.
Publicado: (2016)

Variable Susceptibility to Gallium Compounds of Major Cystic Fibrosis Pathogens
por: Visaggio, Daniela, et al.
Publicado: (2021)

Identification of Exhaled Metabolites in Children with Cystic Fibrosis
por: Weber, Ronja, et al.
Publicado: (2022)

Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells
por: Schamschula, Esther, et al.
Publicado: (2021)

Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis
por: Muilwijk, Danya, et al.
Publicado: (2022)

Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
por: Pedemonte, Nicoletta, et al.
Publicado: (2011)

Case report of compound CFTR variants in Korean siblings with cystic fibrosis: importance of differentiating cystic fibrosis from inflammatory bowel disease
por: Park, Hyejin, et al.
Publicado: (2021)

The Contribution of the Airway Epithelial Cell to Host Defense
por: Stanke, Frauke
Publicado: (2015)

Analysis of the CFTR gene in Venezuelan cystic fibrosis patients, identification of six novel cystic fibrosis-causing genetic variants
por: Sánchez, Karen, et al.
Publicado: (2016)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Microbial Metabolites in Cystic Fibrosis: A Target for Future Therapy?
por: Widder, Stefanie, et al.
Publicado: (2019)

VARUS: sampling complementary RNA reads from the sequence read archive
por: Stanke, Mario, et al.
Publicado: (2019)

Pharmaceutical compounding and dispensing /
Publicado: (2006)

Two Cases of Cystic Fibrosis with Compound Heterozygous Variants Reported for the First Time
por: Yalçıntepe, Sinem, et al.
Publicado: (2020)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

In Silico Identification of Tripeptides as Lead Compounds for the Design of KOR Ligands
por: Stefanucci, Azzurra, et al.
Publicado: (2021)

Export in cystic fibrosis
por: LeBrasseur, Nicole
Publicado: (2004)

Inflammation in Cystic Fibrosis
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_bkn90lraa02m6g5po4vvv3kh9m